Research Partnership launches new patient Living with Ulcerative Colitis (UC) US report
Living with Ulcerative Colitis (UC) is a study conducted amongst 100 adult UC patients in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase summer 2017.
The report is intended to help pharmaceutical companies developing products in this disease area to gain a deeper understanding of how patients come to be diagnosed with UC and how it impacts their day-to-day lives physically, emotionally and socially. It also explores patient attitudes and perceptions towards treatment and the healthcare professionals managing their condition. The report will also identify the types of support patients seek at key stages of their UC journey.
The incidence of UC globally is increasing and in the US alone it affects approximately one million people. Head of Living with, Mariel Metcalfe commented, “We have already conducted this study in the EU, however, due to demand from our clients, we have expanded this report to cover the US as well. This report will provide comprehensive, quantitative insights into patient behaviours. In addition to this we are also including a qualitative element, to add a depth of insight into patient feelings at key stages of their journey.”
Living with UC is just one in a series of reports offering comprehensive insight into the chronic disease patient journey from pre-diagnosis to stabilisation. Living with NASH (US) is also being published this summer and Living with UC (EU), Lupus (SLE) (EU & US), Crohn’s (EU & US), Rheumatoid Arthritis (EU & US) and PsA (EU) reports have recently been published and are available to purchase.